Latest Gedeon Richter Plc Stories
BUDAPEST, Hungary and DUBLIN, Jan. 20, 2015 /PRNewswire/ -- Gedeon Richter Plc.
- Potential Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder - DUBLIN and BUDAPEST, Hungary, Jan.
Triggers euro 2.5 Million (~$3 Million) Milestone Payment from Gedeon Richter CRANBURY, N.J., Dec. 29, 2014 /PRNewswire/ -- Palatin Technologies, Inc.
CAKOVEC, Croatia, October 13, 2014 /PRNewswire/ -- As a specialty pharmaceutical company, Gedeon Richter remains focused on innovating and searching for advanced multichannel
CRANBURY, N.J. and BUDAPEST, Hungary, Sept. 3, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN; hereinafter: "Palatin") and Gedeon Richter Plc.
MORRISTOWN, N.J., and BUDAPEST, HUNGARY, Dec. 16, 2010 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) ("Watson") and Gedeon Richter Plc ("Richter") today announced that Watson's subsidiary, Watson Laboratories, Inc.
NEW YORK and BUDAPEST, Hungary, Sept. 30 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc.
- The parings of haberdine; also, any kind of fragments.